(Updated - December 16, 2024 6:16 AM EST)

JPMorgan analyst Brian Cheng upgraded Zymeworks (NASDAQ: ZYME) from Neutral to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE